All news

Spineway, specialist in designing innovative surgical implants and instruments for treating severe disorders of the spinal column, expects the gradual return of spinal surgeries worldwide. In order to meet the needs of this recovery, the company has welcomed some of its employees back on the premises after implementing the new health and safety rules required following the lifting of the COVID-19 stay-at-home order to lessen the risk of the virus spreading to employees. For now, employees whose jobs are conducive to working remotely remain at home. This will change as needs evolve due to the return to activity and the health authorities’ recommendations.

Spineway, specialist in designing innovative surgical implants and instruments for treating severe disorders of the spinal column, announces the signature of an exclusive agreement for the distribution of its products in Japan with MURANAKA Medical Instruments.

Spineway’s Board of Directors, at a meeting held on 15 April 2020 chaired by Stéphane Le Roux, closed the 2019 annual accounts. The Group’s Statutory Auditors have audited these accounts and their reports are being prepared.

2019 was a particularly active year for the SPINEWAY group as it redeployed its activities in previously covered areas, completely reorganized its teams and renewed half its Executive Committee at the end of 2019. Spineway also strengthened its financial position thanks to a financing agreement with Negma Group1 in order to ensure organic growth and finance new development projects. The Group thus generated total revenue of €5 015K for 2019.

Spineway, specialist in innovative spinal implants, announces the appointment of Myriam Denis as Chief Financial Officer. Her arrival allows Spineway to expand its Executive Committee and create a structure that will ensure the implementation of its development plan.